300633 Sonoscape Medical Corp.
- 40.65
- +0.45+1.12%
Sonoscape Medical Corp. News
The establishment of Healthcare (300633.SZ) plans to pay 3.2 yuan for every 10 shares in 2023, excluding interest on May 29
Medical (300633.SZ) announcement. The company plans to distribute cash for every 10 shares to all shareholders in 2023...
SonoScape Medical Corp. (SZSE:300633) Adds CN¥666m in Market Cap and Insiders Have a 56% Stake in That Gain
Key Insights Insiders appear to have a vested interest in SonoScape Medical's growth, as seen by their sizeable ownership The top 4 shareholders own 53% of the company 27% of SonoScape Medical is
Nomura Adjusts Sonoscape Medical's Price Target to 49.97 Yuan From 55.47 Yuan, Keeps at Buy
03:34 AM EDT, 04/29/2024 (MT Newswires) -- Nomura Adjusts Sonoscape Medical's Price Target to 49.97 Yuan From 55.47 Yuan, Keeps at Buy Price (RMB): ¥41.46, Change: ¥+0.27, Percent Change: +0.66%
Kaili Healthcare (300633.SZ) announced first-quarter results, net profit of 100 million yuan, a decrease of 27.65%
According to the Zhitong Finance App, Kaili Healthcare (300633.SZ) released its report for the first quarter of 2024. The company's revenue was 479 million yuan, an increase of 1.33% over the previous year. Net profit attributable to shareholders of listed companies was 100 million yuan, a year-on-year decrease of 27.65%. Net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 92.22,900 yuan, a year-on-year decrease of 26.55%. Basic earnings per share were $0.2326.
Open Healthcare (300633.SZ): Net profit for 2023 increased by 22.88% to 454 million yuan, and plans to pay 10 to 3.2 yuan
On April 11, Gelonghui Healthcare (300633.SZ) announced its 2023 annual report. In 2023, the company achieved operating income of 2.120 billion yuan, an increase of 20.29%; net profit attributable to shareholders of listed companies was 454 million yuan, up 22.88% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 442 million yuan, an increase of 29.52% year on year; basic income per share was 1.06 yuan; it plans to distribute a cash dividend of 3.2 yuan (tax included) to all shareholders for every 10 shares.
Is There An Opportunity With SonoScape Medical Corp.'s (SZSE:300633) 48% Undervaluation?
Key Insights Using the 2 Stage Free Cash Flow to Equity, SonoScape Medical fair value estimate is CN¥67.53 SonoScape Medical's CN¥35.38 share price signals that it might be 48% undervalued The CN
Risks To Shareholder Returns Are Elevated At These Prices For SonoScape Medical Corp. (SZSE:300633)
With a price-to-earnings (or "P/E") ratio of 40.1x SonoScape Medical Corp. (SZSE:300633) may be sending bearish signals at the moment, given that almost half of all companies in China have P/E ratios
Guotai Junan: The medical device procurement side is expected to improve season by season, and the boom has quietly arrived
The medical device procurement side is expected to improve quarter by season, and the boom has quietly arrived.
Established Healthcare (300633.SZ): Overseas business is expected to maintain a steady growth trend in the future
On March 12, Gelonghui Healthcare (300633.SZ) was recently surveyed by a specific target on “the development status and prospects of the company's overseas business?” The company replied that as the earliest domestic medical equipment manufacturer to start overseas business, the company's medical equipment exports have been among the highest in the industry for many years. The company has been adhering to the “domestic+international” market development for a long time. In recent years, the company's overseas business revenue has continued to grow. It has broken through the 100 million US dollar mark in 2022 and continued to grow in 2023. The overseas market is extremely broad. Through years of hard work, the company has established a global coverage of 170
Establishment of medical treatment (300633.SZ): By the end of 2023, the company's soft mirror products were officially installed in domestic tertiary hospitals, reaching a total of more than 430
On March 12, Gelonghui Medical (300633.SZ) was recently surveyed by specific subjects on “How many domestic tertiary hospitals have installed the company's soft mirror products?” The company replied that by the end of 2023, the total number of domestic third-level hospitals that had officially installed the company's soft mirror products had reached more than 430 (not including repeated installations), which had formed a relatively good window demonstration effect. As an interventional surgical device, the clinical requirements for using a soft microscope are high. In particular, the admission threshold for tertiary hospitals is higher. The number of newly installed tertiary hospitals in the company is increasing every year, which represents the good market recognition of the company's soft mirror products.
SonoScape Medical (SZSE:300633) Shareholders Have Earned a 19% CAGR Over the Last Three Years
SonoScape Medical Corp. (SZSE:300633) shareholders might be concerned after seeing the share price drop 17% in the last quarter. But that shouldn't obscure the pleasing returns achieved by sharehol
Established Healthcare (300633.SZ): A total cost of 91.829,500 yuan to repurchase 2,077,400 shares
Gelonghui (300633.SZ) announced on February 29, 2024, that as of February 29, 2024, the company had repurchased 2,077,400 shares of the company's shares through centralized bidding transactions, accounting for 0.48% of the company's current total share capital. The highest transaction price was 49.37 yuan/share, the lowest transaction price was 32.31 yuan/share, and the transaction amount was 91.8295.25 million yuan (excluding transaction fees).
Capital Allocation Trends At SonoScape Medical (SZSE:300633) Aren't Ideal
What trends should we look for it we want to identify stocks that can multiply in value over the long term? One common approach is to try and find a company with returns on capital employed (ROCE) th
SonoScape Medical Corp.'s (SZSE:300633) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
SonoScape Medical (SZSE:300633) has had a great run on the share market with its stock up by a significant 19% over the last week. Given the company's impressive performance, we decided to study its
The establishment of Healthcare (300633.SZ) has repurchased a total of 20.94 million shares at a cost of 89.97 million yuan
A medical (300633.SZ) announcement was issued. As of January 31, 2024, the company has repurchased 2 of the company's shares...
We Ran A Stock Scan For Earnings Growth And SonoScape Medical (SZSE:300633) Passed With Ease
Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks' without any revenue, let alone profit. Unfortunately, these high risk investments
Does SonoScape Medical (SZSE:300633) Have A Healthy Balance Sheet?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously said that 'Volatility is far from synonymous with risk.' When we think about how
Open Medical (300633.SZ): Up to now, the company's soft mirror products have been officially installed in more than 400 tertiary hospitals in China
On January 12, Gelonghui Medical (300633.SZ) was recently surveyed by specific subjects on “How many domestic tertiary hospitals have installed the company's soft mirror products?” The company replied that up to now, the company's soft mirror products have been officially installed in more than 400 tertiary hospitals in China. Compared with pure diagnostic equipment such as ultrasound, soft mirrors are clinically demanding for use as surgical equipment for interventional treatment, and they must be highly approved by doctors before they can be successfully installed. The number of newly installed tertiary hospitals in the company is increasing every year, which represents the good market recognition of the company's soft mirror products. There are about 3,000 tertiary hospitals and companies in China
Established Healthcare (300633.SZ): IVUS is the company's seed business entering the cardiovascular field and is a long-term development project
Gelonghui, January 12丨Kaili Medical (300633.SZ) recently received research from a specific target. “The company won the bid for IVUS products collected in Zhejiang Province. What are future expectations?” The company replied that the company's IVUS products were officially launched in the first half of 2023, and the launch period is relatively short. The shortlisted collection project in Zhejiang Province will help speed up brand promotion and rapidly increase product sales, but there is still a big gap from leading brands in the industry. IVUS is the company's seed business entering the cardiovascular field. It is a long-term development project. In the future, the company will use IVUS as the basis to steadily expand new cardiovascular systems
Insiders Are the Top Stockholders in SonoScape Medical Corp. (SZSE:300633), and the Recent 4.0% Drop Might Have Disappointed Them
Key Insights Insiders appear to have a vested interest in SonoScape Medical's growth, as seen by their sizeable ownership A total of 4 investors have a majority stake in the company with 53% ownersh
Analysis
Price Target
No Data
